The stock of bioMmune Technologies Inc (CVE:IMU) is a huge mover today! The stock decreased 6.78% or $0.04 on September 13, hitting $0.55. About 21,850 shares traded hands or 25.14% up from the average. bioMmune Technologies Inc (CVE:IMU) has risen 6.00% since August 14, 2016 and is uptrending. It has underperformed by 10.49% the S&P500.
The move comes after 5 months negative chart setup for the $17.25 million company. It was reported on Sep, 13 by Barchart.com. We have $0.50 PT which if reached, will make CVE:IMU worth $1.73M less.
Biommune Technologies Inc, formerly MC Partners Inc, is a Canada biopharmaceutical company. The company has a market cap of $17.25 million. The Firm is a research and development issuer. It currently has negative earnings. The Firm is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.